Glioblastoma Metabolomics—In Vitro Studies

In 2016, the WHO introduced new guidelines for the diagnosis of brain gliomas based on new genomic markers. The addition of these new markers to the pre-existing diagnostic methods provided a new level of precision for the diagnosis of glioma and the prediction of treatment effectiveness. Yet, despi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaroch, Karol, Modrakowska, Paulina, Bojko, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153257/
https://www.ncbi.nlm.nih.gov/pubmed/34068300
http://dx.doi.org/10.3390/metabo11050315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153257/
https://www.ncbi.nlm.nih.gov/pubmed/34068300
http://dx.doi.org/10.3390/metabo11050315

Ejemplares similares